PuSH - Publication Server of Helmholtz Zentrum München

100 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Buergy, D.* et al.: Stereotactic or conformal radiotherapy for adrenal metastases - patient characteristics and outcomes in a multicenter analysis. Int. J. Cancer, DOI: 10.1002/ijc.33546 (2021)
2.
Finke, I.* et al.: Small-area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany. Int. J. Cancer, DOI: 10.1002/ijc.33553 (2021)
3.
So, R.* et al.: Long-term exposure to air pollution and liver cancer incidence in six European cohorts. Int. J. Cancer 149, 1887–1897 (2021)
4.
Tawk, B.* et al.: Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy. Int. J. Cancer, DOI: 10.1002/ijc.33842 (2021)
5.
Barahona Ponce, C.* et al.: Arsenic and gallbladder cancer risk: Mendelian randomization analysis of European prospective data. Int. J. Cancer 146, 2648–2650 (2020)
6.
Bogner, E.-M. et al.: miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance. Int. J. Cancer 147, 3523-3538 (2020)
7.
Bossé, Y.* et al.: Transcriptome-wide association study reveals candidate causal genes for lung cancer. Int. J. Cancer 146, 1862-1878 (2020)
8.
Gerke, J.S.* et al.: Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma. Int. J. Cancer 146, 2036-2046 (2020)
9.
Sato, M. et al.: Loss of the cystine/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice. Int. J. Cancer 147, 3224-3235 (2020)
10.
Yin, S.* et al.: SI-CLP inhibits the growth of mouse mammary adenocarcinoma by preventing recruitment of tumor-associated macrophages. Int. J. Cancer 146, 1396-1408 (2020)
11.
Stangl, S. et al.: Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Int. J. Cancer 142, 1911-1925 (2018)
12.
von Neubeck, B. et al.: An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo. Int. J. Cancer 143, 2065-2075 (2018)
13.
Wilke, C. et al.: Expression of miRNA-26b-5p and its target TRPS1 is associated with radiation exposure in post-Chernobyl breast cancer. Int. J. Cancer 142, 573-583 (2018)
14.
Wilke, C. et al.: A genomic copy number signature predicts radiation exposure in post-Chernobyl breast cancer. Int. J. Cancer 143, 1505-1515 (2018)
15.
Gu, F.* et al.: Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. Int. J. Cancer 141, 1794-1802 (2017)
16.
Pötzl, J. et al.: Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-γ and induces NK cell-dependent lymphoma control without other immunotherapies. Int. J. Cancer 140, 2125-2133 (2017)
17.
Smida, J. et al.: Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma. Int. J. Cancer 141, 816-828 (2017)
18.
Harnicek, D. et al.: Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair. Int. J. Cancer 139, 467-479 (2016)
19.
Consonni, D.* et al.: Lung cancer risk among bricklayers in a pooled analysis of case-control studies. Int. J. Cancer 136, 360-371 (2015)
20.
Ermolayev, V. et al.: Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model. Int. J. Cancer 137, 1107-1118 (2015)